why choose us

First received: December 13, 2022

Clinical Trial: A Study to Assess the Effects on the Single-Dose Drug Levels of Mavacamten in Healthy Participants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy Participants

Study Type: INTERVENTIONAL


Official Title: An Open-label, Randomized, Single-dose, Three-way Crossover Study to Establish Bioequivalence of 5 mg Mavacamten Capsule 1 and 5 × 1 mg Mavacamten Capsule 2 to 5 mg Mavacamten Capsule 2 in Healthy Par

Brief Summary: The purpose of this study is to assess the effects on the single-dose drug levels of mavacamten in healthy participants.

Read more